The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Symposium

[S11☆]Game Changer for Next-Generation Drug Discovery —Leveraging the Latest Research Information from AMED BINDS and Connecting It to Drug Discovery—

Fri. Mar 27, 2026 1:10 PM - 4:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 7:10 AM UTC
Room 05 (F401, Bldg. 4, Area 2 [4F])
Organizer: Kazutake Tsujikawa (Grad. Sch. Pharm. Sci., UOsaka), Tatsuya Zenkoh (Grad. Sch. Phar. Sci., UTokyo)
Numerous diseases, including intractable and rare diseases, remain poorly understood in terms of their pathophysiology, resulting in delayed drug development. Therefore, there is a strong expectation that academic researchers will advance fundamental research and advance drug discovery to make contributions to society. To meet these expectations, it is essential to build foundational technologies based on cutting-edge science, integrate analytical techniques, and promote collaboration across research fields. Moreover, the accumulation of insights and knowledge fosters new ideas and discoveries. This symposium will introduce challenging and innovative cutting-edge research conducted by researchers from diverse research fields participating in AMED BINDS. BINDS supports not only the research technologies developed at each hub, but also analytical foundation techniques using advanced equipment, research materials such as compound libraries, and the synthesis of compound derivatives. We hope this symposium will serve a game-changer in pioneering next-generation pharmaceutical and drug discovery research based on BINDS, and we look forward to deepening discussions with participants.
1:10 PM - 1:14 PM JST(4:10 AM - 4:14 AM UTC)

オーガナイザー挨拶
辻川 和丈（阪大院薬）

1:14 PM - 1:24 PM JST(4:14 AM - 4:24 AM UTC)

AMED BINDSプログラムスーパーバイザー挨拶
井上 豪（阪大院薬）

1:24 PM - 1:47 PM JST(4:24 AM - 4:47 AM UTC)

[S11-1]New progress in academia drug discovery screening: Implementation of Affinity Selection-Mass Spectrometry (AS-MS) technology at Drug Discovery Initiative

○Riyo Imamura1 (1. UTokyo)
1:47 PM - 2:10 PM JST(4:47 AM - 5:10 AM UTC)

[S11-2]Cell-Free Protein Synthesis for Drug Discovery: From Tough-Target Production to Target Deconvolution

○Hiroyuki Takeda1 (1. PROS, Ehime Univ.)
2:10 PM - 2:33 PM JST(5:10 AM - 5:33 AM UTC)

[S11-3]Support for Metabolome and Proteome Analyses in the AMED BIND Project

○Takeshi Bamba1 (1. MIB, Kyushu Univ.)
2:33 PM - 2:56 PM JST(5:33 AM - 5:56 AM UTC)

[S11-4]Development and applications of highly functional intestinal monolayers derived from human iPS cells using organoid technology

○Tatsuya Inui1,2, Hiroyuki Mizuguchi1,2,3,4,5 (1. Grad. Sch. Pharm. Sci., UOsaka, 2. NIBN, 3. MEI cent., UOsaka, 4. OTRI, UOsaka, 5. CiDER, UOsaka)
2:56 PM - 3:19 PM JST(5:56 AM - 6:19 AM UTC)

[S11-5]BSL3 cryo-electron microscopy for drug discovery of infectious diseases

○Hideo Fukuhara1, Katsumi Maenaka1,2,3 (1. Hokkaido U, 2. Hokkaido U, 3. Kyushu U)
3:19 PM - 3:42 PM JST(6:19 AM - 6:42 AM UTC)

[S11-6]CrypToth: A Computational Approach to Discover Hidden Ligand-Binding Pockets for Novel Drug Target Discovery

○Jun Koseki1 (1. AIST CMB)
3:42 PM - 4:05 PM JST(6:42 AM - 7:05 AM UTC)

[S11-7]Advancement of Organic Synthesis for Diverse Modalities and Its Contribution to Life Science and Drug Discovery

○Satoshi Yokoshima1 (1. Grad Sch Pharm Sci, Nagoya Univ)
4:05 PM - 4:10 PM JST(7:05 AM - 7:10 AM UTC)

総括
善光 龍哉（東大院薬）

Back to Category List